RLX Technology Inc. (RLX) Earnings Call Transcript & Summary
May 20, 2022
Earnings Call Speaker Segments
Sam Tsang
executiveThanks so much. Good day, everybody, and thanks for joining the RLX Technologies First Quarter 2020 Earnings Conference Call. Earlier today, the company's financial and operational results went out through PR newswire services and are now posted online. You may also read the earnings press release by going to the IR section of our website, ir.rh.com. Joining us on today's call are our CFO, Mr. Chao Lu, and me, Sam Tsang, Head of Investor Relations. Before we move on, please be aware that today's discussion will include forward-looking statements made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995; these statements typically contain words such as may, will, expect, target, estimate, intend, believe, potential, continue or other similar expressions. Forward-looking statements involve inherent risks and uncertainties. A number of business risks and uncertainties could affect the accuracy of these statements and cause actual results to differ materially from those projected or anticipated, and many of those factors are beyond our control. The company, its affiliates, advisors and representatives do not undertake any application to update these forward-looking information, except as required by applicable law. Please be aware that RLX Technology's earnings press release and this conference call include discussions of unaudited GAAP financial measures as well as unaudited non-GAAP financial measures. RLX press release contains a reconciliation of the unaudited non-GAAP measures to the unaudited GAAP measures. I will now hand the call over to Mr. Chao Lu. Please go ahead.
Chao Lu
executiveThanks, Sam, and I appreciate all of you taking the time to be with us on today's call. You're likely already aware that the e-vapor sector right now is being transformed by a combination of regulatory shifts and healthy appetite for safe, high-quality offerings, and both of those things are shaping how we think about our strategy and outlook over the near and medium term. Even though these changes matter a great deal, our confidence in the approach we've chosen has not wavered, and we stay dedicated to establishing and strengthening how much people can trust our brand. We will, as we always have, adhere firmly to the regulatory rules that apply to us and hold fast to our fundamental values, all while delivering premium products of premium quality and meeting what users want through technology that leads the industry, scientific progress, and a flexible way of operating. To give you a broad picture of what is taking place in China's e-vapor sector, I'd like to share a macro-level view of what we're observing and how our company is serving its users and society as we adjust to this industry transformation. After the final administrative measures for e-cigarettes came out in March, the national standard along with a collection of detailed regulatory measures covering e-cigarette licensing, logistics and so on were issued over the last several weeks. We embrace these new rules completely, including the administrative measures and the related implementation guidelines. As additional risks sharpen the regulatory framework with standards and boundaries that are clear, this will work in favor of the industry participants already in place who, like RELX, can adapt to the new infrastructure and simultaneously hold onto their scale and their capacity to handle user experiences and risks both effectively and efficiently. A short summary of the recent regulatory developments appears in our earnings release, and a more thorough analysis can be found in our annual report on Form 20-F; let me now take you through a few of the key developments. To begin, as you may have observed, the final national standards take effect on October 1, 2022, with a transition period running through September 30, 2022. That gives industry participants such as ourselves extra time to adjust more effectively to the new regulatory regime and to reduce disruption for our users and for the e-vapor market. Beyond that, we saw that a regulatory pilot program got underway in April in Huizhou, Guangdong province and Xiamen, Fujian province. Through this pilot program, the new administrative measures were put into practice early in those two cities so that the new supervision process for e-vapor products could be evaluated. In line with the new policy, chosen local retailers started submitting orders for e-vapor products to the local subsidiaries of China tobacco, which from that point on will distribute e-vapor products in local districts, to make sure the process operates without problems before the new mechanism is introduced across the whole country. The national standards also made R&D and quality control standards for e-vapor products in China more stringent, promoting product safety and reducing the room available for counterfeit and unauthorized compatible products. Now I'd like to call attention to the steps we have taken proactively in response to these regulatory changes. When it comes to the licensing requirements set out under the administrative measures, we have already begun applying for manufacturing licenses. We think that, as the top company in this sector, we meet the applicable application criteria. Following what the finalized national standards require, we have already moved to e-vapor cartridges. Those cartridges, along with devices we consider compliant with those standards, are developed and have been handed to the State Tobacco Monopoly Administration for technical review. Our expectation is that these products clear that review and reach the market successfully when the time comes. I also want to bring up a user event held in April at the RELX lab in Shenzhen. Twelve of our current users came to try our new products and watch a presentation from our technologists, which demonstrated deep expertise and technological progress across our product R&D process, plus experiments conducted on site. What we heard from that event, along with findings from our user survey, gave us encouragement to keep pursuing the user-centric product strategy we built to fit the regulatory shifts. Because our adaptation initiative, aimed at improving user experience and satisfaction, rests on our product development capabilities, industry-leading technologies and scientific advancements, we feel confident that most of our current users will respond well to our new products. To make our move into the new operating regime smoother, we are refining our operational structure across numerous assets, including warehousing and logistics, the ERP system and so on. One more point: we recognize that, as of now, responding to shifts in the industry value chain, a number of provinces and cities have announced locally that they will grant over 48,000 retailer licenses in total during the initial stage of regulatory implementation; in our view, that figure should be enough to cover most existing stores' needs across the industry. Thanks to our relentless work to bolster operational capabilities and deliver better products to users, we are optimistic — regarding our capacity to seize the market potential in front of us under the new regulatory landscape. As a trusted e-vapor brand for adult smokers. We will keep strictly complying with new regulations and policies while deepening our commitment to supplying high-quality products and seeking new growth opportunities in the industry. Before we turn to our financial performance, I want to emphasize that in the dynamic market where we operate. Holding fast to our long-term commitment and meeting our responsibilities to our industry, environment and society sits at the heart of our continued success. From our inception, we have strived to push forward a broad range of ESG initiatives within the stakeholder communities we serve. Our 2021 ESG report highlights our actions and progress, among them our low-carbon development strategy and climate-related information disclosures. More recently, we have established targets to reach carbon neutrality across Scope 1 and Scope 2 by 2033 and to achieve net zero for Scope 3, no later than 2050, via 8 key initiatives. We remain unwaveringly committed to strengthening our ESG governance and management system. Establishing and achieving ESG objectives over the long haul so that, in the end, we can advance our sustainable development. At this point, I want to go over a few important developments concerning the financial results for our first quarter. The revenue performance we delivered in Q1 keeps showing how durable our business is, along with our capacity to steer through a market that is shifting quickly, despite the difficulties caused by restrictions tied to COVID-19 and the regulatory landscape that keeps evolving. Starting in early March, demand from distributors has rebounded strongly, since the administrative measures were released and provided near-term clarity for e-vapor operations. Even so, shipment volume for the quarter took a negative hit because production halted at our exclusive production plant, and some of our suppliers in Shenzhen caused delays when the city put a lockdown in place during that stretch of time. On top of that, there was the usual seasonal drag from the weak long Chinese New Year holiday. Our GAAP gross margin, on the other hand, fell compared with a year earlier. The main reason was a change in the mix of our revenue, driven by a larger share of cartridge sales relative to the corresponding period a year ago. Because we kept working to optimize our supply chain and make our operations more efficient, unit cost stayed steady during the first quarter.
Chao Lu
executiveIf we set aside the one-off charges tied to inventory provisions from our GAAP gross margin, our gross margin held at a level comparable to what we saw in Q4 2021. Given macroeconomic uncertainty, stricter COVID-19 measures, and a shifting regulatory landscape, we continue to watch our costs carefully and keep enhancing operational efficiency via a range of programs intended to streamline operations further. There's a saying that uncertainty is the only certainty. Our balance sheet is still solid, with roughly RMB 14.9 billion in cash as of March 31, 2022. In addition, we've brought in positive operating cash flows across each of the last 3 years. We think our solid cash position and healthy cash flows give us a solid base to better adjust to the new regulatory environment and market dynamics. And amid these uncertain times, our strong capital and liquidity position serves as a significant source of confidence for all our stakeholders. Now I'll give a summary overview of our financial results for Q1 2022. Net revenue came to RMB 1.7 billion in Q1 2022, versus RMB 2.4 billion in the comparable period of 2021. That decline stemmed mainly from COVID-19's effect on our Shenzhen production plant, which hurt our production and shipment volume. Gross profit reached RMB 657 million in Q1 2020, versus RMB 1.1 billion in the comparable period of 2021. Gross margin stood at 38.3% in Q1 2022, versus 46% in the comparable period of 2021. That decline came mainly from, first, a shift in product mix; and second, a rise in inventory provision largely tied to recent regulatory developments. Operating expenses came to RMB 33.6 million in Q1 2022, down 97.2% from RMB 1.2 billion in the comparable period of 2021. That drop in operating expenses came mainly from a shift in share-based compensation expenses, which fell to a positive RMB 325.2 million in Q1 2022 from RMB 877.5 million in the comparable period of 2021, made up of: first, share-based compensation expenses of positive RMB 41.9 million recorded in selling expenses; two, share-based compensation expenses of positive RMB 230.1 million recorded in general and administrative expenses; and three, share-based compensation expenses of positive RMB 53.2 million recorded in research and development expenses. That fall in share-based compensation expenses came mainly from changes in the fair value of the share incentive awards the company granted to its employees, driven by swings in the company's share price. Selling expenses dropped by 73.9% to RMB 75.9 million in Q1 2022 from RMB 291.5 million in the comparable period of 2021. That decline came mainly from, first, a fall in share-based compensation expenses; second, a fall in salaries and welfare benefits; and third, a fall in branding material expenses. G&A costs fell 109.3%, landing at a positive RMB 66.4 million for Q1 2022, versus RMB 712.8 million during the identical stretch of 2021. That drop came largely from: number one, lower share-based compensation expenses, and number two, reduced salaries and welfare benefits, though legal and other consulting expenses rising partly countered this. R&D expenses declined 88.7%, reaching RMB 24 million in Q1 2022, down from RMB 211.6 million a year earlier. This decline stemmed mainly from: first, reduced share-based compensation expenses; second, lower salaries and welfare benefits, partly offset by: one, higher depreciation and amortization expenses; and two, greater software and technical service expenses. Operating income reached RMB 623.4 million in Q1 2022, versus an operating loss of RMB 111.9 million during the same quarter of 2021. Income tax expenses totaled RMB 112.6 million in Q1 2022, against RMB 176.3 million in the comparable 2021 period. U.S. GAAP net income came to RMB 687.1 million in Q1 2022, compared with a U.S. GAAP net loss of RMB 267 million in the same period of 2021. Non-GAAP net income stood at RMB 368 million in Q1 2022, versus RMB 610.5 million in the equivalent period of 2021. U.S. GAAP basic and diluted net income per ADS were RMB 0.528 and RMB 0.521, respectively, in Q1 2022. That compares with U.S. GAAP basic and diluted net loss per ADS of RMB 0.174 in the same period of 2021. Non-GAAP basic and diluted net income per ADS were RMB 0.284 and RMB 0.281, respectively, in Q1 2022, compared with RMB 0.398 in the same period of 2021. Turning to the balance sheet. As of March 31, 2022, the company held cash and cash equivalents, restricted cash, short-term bank deposits, short-term investments and long-term bank deposits net of RMB 14.9 billion, compared with RMB 14.4 billion as of March 31, 2021. Of that, roughly USD 1.6 billion was denominated in U.S. dollars as of March 31, 2021 — apologies, 2022. Going forward, we'll keep concentrating on the business elements within our control, including product innovation, cost optimization and operating efficiency, to strengthen our fundamentals and position ourselves to capture future opportunities; we hold confidence in our company's future, along with our industry, and so we have been steadily carrying out our share repurchase program, generating value for our shareholders and long-term investors; that wraps up our prepared remarks today. We'll now open the call for questions. Operator, please go ahead.
Chao Lu
executiveOperator: Our next question comes from Lydia Ling with Citi. Please go ahead.
Lydia Ling
analystHi, management. This is Lydia from Citi. I appreciate the presentation and the update on the first quarter, including what's happening on the regulatory front. I've got two questions for you. First one: as you just noted, there were quite a few regulatory developments this quarter, and we're also seeing a lot of commentary that lays out things like the retail management measures in more detail. So we'd really like more color from you regarding your license application — for instance, what timeline do you anticipate for obtaining your production license? Additionally, we'd like your projection regarding the proportion of retailers who obtain the retail license; and we're also quite eager to hear whatever early reactions exist concerning your new products, since that would be extremely useful for us. Then, regarding my second inquiry — we're likewise aware that nonexclusive retail terms will be in play on the retail side. So in management's view, how does the competitive landscape appear going forward, given that your retailers could be inclined to add additional brands at the store level as a way of securing a license; so thank you. Those are my two questions.
Chao Lu
executiveThanks so much, Lydia. Number one has to do with adjusting our license while we develop products, so we can seize fresh opportunities, and the main issue there is the exclusivity period that subsequent declarations did away with. Now, on the licensing side — our application to modify the manufacturing license has already gone to the State Tobacco Monopoly Administration. We're still waiting on the regulator to approve that manufacturing license, and we feel confident we'll be in the first group of brand manufacturers to get it. On your question about the retail license, our view is that the majority of retailers operating mono brand, which is a smaller format in our sector, are going to receive a retail license at some point within the concession period. On the new product front, we're still in the last stage of testing, with both small and large groups of users involved. We're working hard to accelerate the rollout of our new tobacco flavor cartridge, which is now fully compliant with national standards, while also making sure our pro safety holds up. As for your second question, it's mostly about the exclusivity period for retailers. Based on what we've seen, the competitive landscape hasn't shifted much lately, and it won't change suddenly in the near or medium term. What we think really moves a brand's market share is NPS, meaning Net Promotor Score, along with brand equity, the user base, and R&D capabilities. Every one of those points carries equal weight; exclusivity isn't the bigger factor. So beginning this month, throughout the transitional period, we're hearing from retailers who used to operate monobrand stores in the industry that they've started offering products from other brands. Absolutely — what we've done is commit funds toward those non-exclusivity costs, and that opens doors for us with retailers that previously were tied to other brands and in stores; so before, those retailers may never have stocked our products, or they only did so on an informal, ad hoc sort of basis. So after eliminating that expense, they start leasing our offerings because we hold the largest market position, and our brand awareness can definitely help them boost sales at individual stores. Conversely, certain retailers that previously carried only our brand have started adding items from competing brands, since those companies might offer them free merchandise or promotional items. Even so, based on what we've seen, those other brands haven't produced significant retail revenue, as their brand strength, customer loyalty, and product strengths don't measure up to ours. So to sum up, we think our market leadership rests on these key backers instead of the exclusivity, and we can still hold a relatively high market share moving forward.
Charlie Chen
analystI also have a couple of questions. My first one concerns how sales have been trending during this year's second quarter. As we're aware, essentially every product you offer is in fact sold through offline channels; so could you give us some insight into the ways these COVID control measures might affect your sales, and what the sales momentum looks like up to now; and my second question relates to where things stand with your distribution channels, in particular, I'd like to get a sense of whether any distributors are kind of quitting this business or walking away from you as a result of the regulatory restrictions? And what about the retailers, for instance, the — how are sales, or how are retailers and distributors doing in the pilot areas in Huizhou and Xiamen?
Chao Lu
executiveThanks so much, Charlie. Now on our second quarter sales; as we said during our opening remarks, our net revenues during the first quarter were principally impacted by the COVID restrictions in Shenzhen, which hurt our production volume as well as our shipment volume. So I mean, we've been doing a better job fulfilling orders from our distributors since the latter part of March, and our quarter-to-date performance has been strong and matches what we expected. So at present, we do see some COVID restrictions in certain areas across the country, for instance, in Shanghai and Beijing; so from a retail perspective, these areas don't contribute material sales. And as for your question about the current program and also how the current distributors and retailers are doing. So as for the PAT program, collaboration has gone very smoothly in both Xiamen and Huizhou, and we do see a very strong sales peak as well. So we believe such a PAT program is a good indicator and could help the industry better adapt to the new regulatory changes. And as for the distribution channels, our current distributors, who are the private companies, continue to distribute the products during the transitional period. And given that the business performance has been strong and they make profits from making the concessions, so as of today, we haven't seen any significant attrition among our existing distributors. Thank you for your question.
Peihang Lyu
analystPeihang from CICC here. I actually want to ask two things. The first is about how much inventory the company is carrying, and in particular what the level looks like in the channel. We've also seen that consumers have been stocking up on cartridges lately, so in your view, roughly how many cartridges do you estimate users have put away? My second question concerns cost reduction — what steps have you already taken, and what do you intend to do going forward?
Wang Ying
executiveThanks, Peihang. The first part covers inventory levels for each of our stakeholders as well as for us, and the second part is mostly about measures to optimize costs. On the first question, if you look at our balance sheet, you'll see inventory has stayed fairly low, falling from almost RMB 600 million in Q4 to RMB 267 million in Q1. Of that figure, just a small share is finished goods, so given how effective the national standards have been and because of certain slow-moving SKUs, we've acted very prudently and set up sufficient inventory provisions over the last 2 quarters. As for our trade inventory — meaning what sits in our distribution channels — it dropped considerably across Q1 because of COVID-19 restrictions at our Shenzhen factory. Conditions have steadily gotten better starting in Q2, though we've kept distributing our products carefully, since we don't want the inventory to have — don't want channels holding excessive inventory. Last is our users' inventory. From our membership data, we know that the typical monthly cartridge purchase per user has fallen by a moderate amount since December of last year. As things stand, we remain in the transition period through September 30, and by that point we'll have clearer visibility into the estimated inventory turnover days for our existing product portfolio held by users. Your second question deals with cost optimization initiatives; we work to optimize costs across many areas, from the unit cost of each bond to packaging, logistics, and warehousing. In the past, we managed to lower our packaging and warehousing costs by redesigning our packaging and raising our warehousing utilization rates. On the unit cost of each bond, we stay in constant communication with our suppliers. We've been pushing procurement costs down, helped by technological advancements and automation in our supply chain. Looking ahead, we'll keep optimizing costs in these areas, from the unit cost of each bond to our product design, along with ongoing improvements in how we utilize our supply chain process. Thank you for your question.
Peihang Lyu
analystThat was quite clear and thorough.
Chao Lu
executiveWe appreciate you being with us once more today. Should any additional questions come up, don't hesitate to reach out to the Investor Relations team at RLX Technologies using the contact details listed on our website, or to TPG Investor Relations. Thanks.
Operator
operatorThanks. That brings us to the end of today's conference call, everyone. We appreciate everyone joining us for today's presentation. At this point you're welcome to hang up, and have a great day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete RLX Technology Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to RLX Technology Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in RLX Technology Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.